| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.5M | +104.3% |
| SG&A Expense | $8.7M | +133.8% |
| Operating Income | -$12.2M | -124.5% |
| Pre-tax Income | -$12.4M | -133.2% |
| Income Tax | -$503 | — |
| Net Income | -$12.3M | -133.2% |
| EPS (Basic) | -$12.52 | -4371.4% |
| EPS (Diluted) | -$12.52 | -4371.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.8M | +347.6% |
| Current Assets | $16.5M | +297.2% |
| Total Assets | $94.3M | +2164.1% |
| Current Liabilities | $3.2M | +785.9% |
| Total Liabilities | $30.0M | +8274.7% |
| Stockholders' Equity | -$10.1M | -365.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.8M | -80.5% |
| Investing Cash Flow | $3.8M | — |
| Financing Cash Flow | $16.7M | +1344.5% |